NCT03497702 Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer Status UNKNOWN Phase PHASE2
NCT03387553 HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer Status COMPLETED Phase EARLY_PHASE1
NCT03381092 Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy Status UNKNOWN Phase N/A
NCT03375892 The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure Status COMPLETED Phase NA
NCT03361800 Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC Status TERMINATED Phase EARLY_PHASE1
NCT03247478 Computed Tomography (CT) Reconstruction for Axillary Lymph Node Structure Status COMPLETED Phase N/A
NCT03219476 Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT03212170 FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer Status COMPLETED Phase PHASE2
NCT03206203 Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT02802553 Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions Status ACTIVE_NOT_RECRUITING Phase NA
NCT02773784 Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer. Status COMPLETED Phase N/A
NCT02333890 A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer Status UNKNOWN Phase PHASE2
NCT02244580 Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM" Status COMPLETED Phase NA
NCT02190227 RNA Disruption Assay (RDA) Response Prediction in Neoadjuvant Chemotherapy Breast Cancer Treatment Status COMPLETED Phase PHASE2